The Sagar Hospitals® is a landmark healthcare services institution that enjoys a unique reputation of being a popular destination for both Indian and international patients seeking treatment at an affordable cost. The Sagar Hospitals® has lent its unique dimension of human touch to the complex science of healthcare. The Sagar Hospitals` mission is to maintain a high degree of quality and care to any patient seeking medical aid is sacrosanct to its highly acclaimed and equipped team.

Department of Science & Technology (DST) was established in May 1971, with the objective of promoting new areas of Science & Technology and to play the role of a nodal department for organising, coordinating and promoting S&T activities in the country.

The University Institute of Pharmaceutical Sciences of the Panjab University is a premier institution of Pharmaceutical Education and Research in the country. The institute has covered a long and glorious journey of 76 years starting from Lahore in 1944 and finally settling to the present campus in Chandigarh at the foothills of Himachal.

Aristo started its operations in 1971 with a manufacturing plant at Aurangabad, marketing operations in Mumbai with a field force of just 30 personnel. Since then Aristo has come a long way... From a turnover of US $ 8500 in 1971 to US $ 64 million in year 2000.

To improve the quality of life of the people of Canada and India by building and strengthening intellectual and cultural linkages through research, dialogue and exchange

AXA Parenterals Ltd. is into manufacturing & marketing sterile of parenteral preparations, life saving medicines and hospital products.
AXA Parenterals Ltd. has first of its kind I.V. Fluid plant in Roorkee, Uttarakhand, the hilly state of India. AXA manufactures Intravenous Fluids in Polyethylene containers under aseptic conditions using the latest “State-Of-The-Art” AFFS Technology.

Troikaa mainly focuses on Novel Drug Delivery Systems (NDDS). The company firmly believes in providing superior therapeutic benefits by improvising the formulations through Innovative Technologies.
Six patents have been filed in various areas of drug delivery. To handle competition, Troikaa adopted various multifaceted strategies to help stand their ground in the competitive market. Another fact that helps us stand out is their high quality products.

United Biotech has been a trend setter of new standards and is among the fastest growing companies in the Indian pharmaceutical Industry.

Headquartered in Mumbai India, GenPharma is with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.
Everyday, they strive to discover new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of functioning.

About Author: Jadhav Ramulu 1, P. Goverdhan2
1 Vaagdevi College of Pharmacy, Hanamkonda-Warangal (Affiliated to Kakatiya University), A.P-506002, INDIA
2 Head of the department, pharmacology, Vaagdevi College of Pharmacy, Hanamkonda-Warangal, A.P-506002, INDIA

Abstract
Computer aided drug design(CADD) is an emerging tool for research and drug development process as it reduce the time taken for the process of drug development and expense. Several new technologies have been developed and applied in drug R & D to shorten the research cycle and to reduce the expenses. In computer aided drug design process so many computational tools are used such as over viewing tools, homology modeling, and homology modeling programs, molecular dynamics, molecular docking and QSAR descriptors. This article provides a brief idea on computer aided drug design process and list of software used.

Headquartered in Mumbai India, GenPharma is with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.
Everyday, they strive to discover new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of functioning.

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.